Citation Information :
Reghukumar A, Nair LJ, Jaya P, Gurudas A, Sasidharan KV, Simon DG, Shanmugham M. Coronavirus Disease-associated Mucormycosis Presenting as Thyroid Abscess: A Rare Case Scenario. J Acad Clin Microbiol 2024; 26 (2):51-53.
Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, several countries, especially India, showed an alarming increase in coronavirus disease (COVID)-associated mucormycosis (CAM) cases, particularly in those with dysglycemia and the use of corticosteroids. Disseminated mucormycosis can affect all organs, but isolated involvement of the thyroid gland is extremely rare. Here, we describe a case of isolated mucormycosis of the thyroid gland in a 70-year-old woman with uncontrolled diabetes mellitus who had recovered from severe SARS-CoV-2 infection. The thyroid gland is immune to infections because of its high vascularity, high iodine content, and capsule. Fungal infections of the thyroid gland are very rare. To the best of our knowledge, this is the first case of post-COVID-19-associated mucormycosis of the thyroid gland reported in the literature.
National Academies of Sciences, Engineering, and Medicine. A long COVID definition: a chronic, systemic disease state with profound consequences. Washington, DC: The National Academies Press; 2024.
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection 2021;49(5):833–853. DOI: 10.1007/s15010-021-01670-1
Mascarella MA, Schweitzer L, Alreefi M, et al. The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy. J Otolaryngol Head Neck Surg 2019;48:49. DOI: 10.1186/s40463-019-0376-1
Walther G, Wagner L, Kurzai O. Updates on the taxonomy of mucorales with an emphasis on clinically important taxa. J Fungi 2019;5(4):106. DOI: 10.3390/jof5040106
Patel A, Agarwal R, Rudramurthy SM, et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg Infect Dis 2021;27(9):2349–2359. DOI: 10.3201/eid2709.210934
Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019;19(12):e405–e421. DOI: 10.1016/S1473-3099(19)30312-3
Morales-Franco B, Nava-Villalba M, Medina-Guerrero EO, et al. Host-pathogen molecular factors contribute to the pathogenesis of Rhizopus spp. in diabetes mellitus. Curr Trop Med Rep 2021;8(1):6–17. DOI: 10.1007/s40475-020-00222-1
Rudramurthy SM, Hoenigl M, Meis JF, et al. ECMM/ISHAM recommendations for clinical management of COVID-19-associated mucormycosis in low- and middle-income countries. Mycoses 2021;64(9):1028–1037. DOI: 10.1111/myc.13335
Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest 2020;43(7):1027–1031. DOI: 10.1007/s40618-020-01276-8
Singh AK, Singh R, Joshi SR, et al. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15(4):102146. DOI: 10.1016/j.dsx.2021.05.019
Pal R, Bhadada SK. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr 2020;14(4):513–517. DOI: 10.1016/j.dsx.2020.04.049
Rehman K, Akash MSH, Liaqat A, et al. Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr 2017;27(3):229–236. DOI: 10.1615/CritRevEukaryotGeneExpr.2017019712
Lim S, Bae JH, Kwon HS, et al. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 2021;17(1):11–30. DOI: 10.1038/s41574-020-00435-4
Artis WM, Fountain JA, Delcher HK, et al. A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982;31(12):1109–1114. DOI: 10.2337/diacare.31.12.1109
Howard DH. Acquisition, transport, and storage of iron by pathogenic fungi. Clin Microbiol Rev 1999;12(3):394–404. DOI: 10.1128/CMR.12.3.394
Ibrahim A, Spellberg B, Edwards J. Iron acquisition: a novel prospective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis 2008;21(6):620–625. DOI: 10.1097/QCO.0b013e3283165fd1
Prasad N, Manjunath R, Bhadauria D, et al. Mucormycosis of the thyroid gland: a cataclysmic event in renal allograft recipient. Indian J Nephrol 2018;28(3):232–235. DOI: 10.4103/ijn.IJN_192_17
Irga N, Kosiak W, Jaworski R, et al. Hyperthyroidism secondary to disseminated mucormycosis in a child with acute lymphoblastic leukemia: case report and a review of published reports. Mycopathologia 2013;175(1):123–127. DOI: 10.1007/s11046-012-9584-1